BEYOND A SCREENING
THE NEXT STEP
Recognizing cognitive change starts with the essentials: a patient or family member raising a concern, and validated screens like the Mini-Cog, MoCA, or MMSE during routine visits. These tools are the right first step, and they remain the front line. But brief screenings establish concern more than they quantify it. A patient with higher baseline cognitive reserve can compensate on these. Subtle change is hard to track over time with a snapshot. Increasingly, practices want objective, repeatable data to support evaluation and to follow how a patient changes across visits or once treatment methods are put in place. This is the gap our diagnostics fill. They do not replace the screen or the specialist. They give you measurable, in-office insight that sits between the two.
Patient picture
when a closer look is warranted
Persistent cognitive complaints or memory concerns
Persistent cognitive complaints or memory concerns
Relevant equipment: qEEG, Digital Cognitive screening
Ex. Diagnosis codes: R41.3, R41.840
Cognitive symptoms following a head injury or fall
Cognitive symptoms following a head injury or fall
Relevant Equipment: qEEG and digital cognitive screening
Ex. Diagnosis codes: SO6.9x9A, F07.81
Lingering post-viral and post-COVID cognitive symptoms
Lingering post-viral and post-COVID cognitive symptoms
Recommended Equipment: Autonomic testing, Digital cognitive screening
Ex. Diagnosis codes: U09.9, G93.49, or R41.840
Executive function changes
Executive function changes
Recommended Equipment: qEEG or Digital Cognitive screening
Ex. Diagnosis Codes: R41.844, F07.0
Age-related cognitive concern
Age-related cognitive concern
Recommended Equipment: Digital cognitive screening and qEEG
Example Diagnosis codes: R41.81, G31.84
Brain fog and difficulty concentrating
Brain fog and difficulty concentrating
Recommended Equipment: qEEG, Autonomic testing, and Digital cognitive screening
Ex. Diagnosis codes: R41.840, R41.9
IN-OFFICE DIAGNOSTICS
A MEASURABLE PICTURE OF BRAIN HEALTH
THE CONSULTATIVE DIFFERENCE
BETTER DATA, EARLIER CONVERSATIONS
Objective, in-office data supports earlier and more confident conversations with patients and families. Repeatable baselines let you track the course of an established treatment path or changes that develop outside a care plan. Also, bringing this assessment in-office means fewer handoffs and a smoother experience for the patients who need a closer look. We have more than 20 years experience helping practices source the right diagnostic tools from more than 300 manufacturers. As a master distributor our role is consultative: helping you choose what genuinely fits your patient population, your workflow, and your goals. One conversation, one source.
Schedule a consult
TRUSTED RESOURCES
FOR DEEPER READING
American Academy of Family Physicians
Alzheimer's and dementia care: Diagnosis, management and caregiver support
READ MORE